Search Menu

2015

India rejects Gilead’s patent application for sofosbuvir

Hepatitis C combination from AbbVie licensed in the UK: ombitasvir/paritaprevir/ritonavir (Viekirax) and dasabuvir (Exviera)

HIV prevention budget for 2015 slashed by 50%, then rapidly reinstated

Grassroots demand grows for early access to PrEP in the UK

New York announces new policy to dramatically reduce HIV incidence by 2020

Is HIV weakening over time? Unlikely, and a sense of déjà vu…

Quantification of latent HIV induction by vorinostat

Online video resource – Aidspans video on gay life and death in Ghana

Online article – Journal of Virus Eradication: New open-access journal

Community report – RITA: HIV and kidney disease

January/February 2015: Volume 16 Number 1/2

Post navigation